<DOC>
	<DOCNO>NCT01905787</DOCNO>
	<brief_summary>The purpose study take advance presence two different cohort SCA patient one country , first group include SCA patient Bedouin Arab origin live Israel one century originally come African country Saudi Arabia , patient live north east Israel treat Hematology Unit Emek Medical Center , second group SCA patient African origin come Israel last decade belong original African population , group receive treatment Pediatric Hematology Unit , Dana Children 's Hospital , Ichilov Medical Center . A third group cohort SCA patient treat Schneider Children 's Hospital Hematology Unit . Those patient belong also Israel Arab population patient village African Muslims live many year . The characteristic three group compare characteristic fourth group , cohort Afro-American SCA patient follow treated Pediatric Hematology Unit , Detroit Children 's Medical Center , Detroit , Michigan , USA .</brief_summary>
	<brief_title>Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities , Multicenter Study</brief_title>
	<detailed_description>Group 1 - Emek group - ( EMC ) : 100 patient include study , include Homozygous SCA patient Sickle Cell β Thalassemia Patients ( β0 β+ patient include ) . Group 2 - Dana group - ( DMC ) : 50 patient include study . Group 3 - Schneider group - ( ShMC ) : 50 patient include study . Group 4 - Detroit group - ( WYUMC ) : 100 patient include study , Homozygous SCA patient Sickle Cell β Thalassemia Patients ( β0 β+ ) include ) . Patients Sickle cell hemoglobin C ( SC ) Sickle cell hemoglobin D ( SD ) disease include part study analysis due small number patient expect , investigator encourage report data patient analysis . Age : No age limit , patient include since diagnosis till age 40 since teenager young adult often treat pediatric hematology unit . Gender : Males Females include study . Pregnant patient : Pregnancy consider exclusion criterion . Data pregnancy Hydroxyurea treatment female male include , include malformation offspring . It need emphasized recommendation patient sex stop Hydroxyurea treatment last three month conception . Data collection : Data collect medical file . Demographic family history laboratory finding diagnosis include . Genetic mutation β globin gene patient Sickle Cell β thalassemia include previously analyze record medical file . Also α globin mutation SCA haplotype include previously analyze part data already present medical file . Further genetic analysis include β α globin mutation , haplotype xmn1 polymorphism include extension study analysis integral part initial study unless perform present study . Clinical complaint last 10 year summarize . Iron chelation Hydroxyurea treatment give last 10 year summarize . Complications diagnose age also record . Exclusion criterion : - Patients without sufficient data medical file due lack regular follow exclude . - Patients give explicit refuse participation . Inclusion criterion : - All patient currently treat follow center Israel include . - A similar number patient age range diagnosis include whole cohort Detroit MC . Since Detroit MC significant large number patient , criterion patient 's selection center cohort match gender age Israel patient .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Thalassemia</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<criteria>All patient follow center participate study . Pregnancy consider exclusion criterion . Patients SC SD disease include .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>